Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Cell Cycle Proteins. Found 35 abstracts

no pagination
Mukherjee K, Sha X, Magimaidas A, Maifrede S, Skorski T, Bhatia R, Hoffman B, Liebermann DA. Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemia. Oncotarget. 2017 Feb 14;8(7):10809-21.   PMCID: PMC5355225
Teye EK, Sido A, Xin P, Finnberg NK, Gokare P, Kawasawa YI, Salzberg AC, Shimko S, Bayerl M, Ehmann WC, Claxton DF, Rybka WB, Drabick JJ, Wang HG, Abraham T, El-Deiry WS, Brodsky RA, J Hohl R, Pu JJ. PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features. Oncotarget. 2017 May 02;8(18):29887-905.   PMCID: PMC5444711
Dunning AM, Michailidou K, Kuchenbaecker KB, Thompson D, French JD, Beesley J, Healey CS, Kar S, Pooley KA, Lopez-Knowles E, Dicks E, Barrowdale D, Sinnott-Armstrong NA, Sallari RC, Hillman KM, Kaufmann S, Sivakumaran H, Moradi Marjaneh M, Lee JS, Hills M, Jarosz M, Drury S, Canisius S, Bolla MK, Dennis J, Wang Q, Hopper JL, Southey MC, Broeks A, Schmidt MK, Lophatananon A, Muir K, Beckmann MW, Fasching PA, Dos-Santos-Silva I, Peto J, Sawyer EJ, Tomlinson I, Burwinkel B, Marme F, Guenel P, Truong T, Bojesen SE, Flyger H, Gonzalez-Neira A, Perez JI, Anton-Culver H, Eunjung L, Arndt V, Brenner H, Meindl A, Schmutzler RK, Brauch H, Hamann U, Aittomaki K, Blomqvist C, Ito H, Matsuo K, Bogdanova N, Dork T, Lindblom A, Margolin S, Kosma VM, Mannermaa A, Tseng CC, Wu AH, Lambrechts D, Wildiers H, Chang-Claude J, Rudolph A, Peterlongo P, Radice P, Olson JE, Giles GG, Milne RL, Haiman CA, Henderson BE, Goldberg MS, Teo SH, Yip CH, Nord S, Borresen-Dale AL, Kristensen V, Long J, Zheng W, Pylkas K, Winqvist R, Andrulis IL, Knight JA, Devilee P, Seynaeve C, Figueroa J, Sherman ME, Czene K, Darabi H, Hollestelle A, van den Ouweland AM, Humphreys K, Gao YT, Shu XO, Cox A, Cross SS, Blot W, Cai Q, Ghoussaini M, Perkins BJ, Shah M, Choi JY, Kang D, Lee SC, Hartman M, Kabisch M, Torres D, Jakubowska A, Lubinski J, Brennan P, Sangrajrang S, Ambrosone CB, Toland AE, Shen CY, Wu PE, Orr N, Swerdlow A, McGuffog L, Healey S, Lee A, Kapuscinski M, John EM, Terry MB, Daly MB, Goldgar DE, Buys SS, Janavicius R, Tihomirova L, Tung N, Dorfling CM, van Rensburg EJ, Neuhausen SL, Ejlertsen B, Hansen TV, Osorio A, Benitez J, Rando R, Weitzel JN, Bonanni B, Peissel B, Manoukian S, Papi L, Ottini L, Konstantopoulou I, Apostolou P, Garber J, Rashid MU, Frost D, Izatt L, Ellis S, Godwin AK, Arnold N, Niederacher D, Rhiem K, Bogdanova-Markov N, Sagne C, Stoppa-Lyonnet D, Damiola F, Sinilnikova OM, Mazoyer S, Isaacs C, Claes KB, De Leeneer K, de la Hoya M, Caldes T, Nevanlinna H, Khan S, Mensenkamp AR, Hooning MJ, Rookus MA, Kwong A, Olah E, Diez O, Brunet J, Pujana MA, Gronwald J, Huzarski T, Barkardottir RB, Laframboise R, Soucy P, Montagna M, Agata S, Teixeira MR, Park SK, Lindor N, Couch FJ, Tischkowitz M, Foretova L, Vijai J, Offit K, Singer CF, Rappaport C, Phelan CM, Greene MH, Mai PL, Rennert G, Imyanitov EN, Hulick PJ, Phillips KA, Piedmonte M, Mulligan AM, Glendon G, Bojesen A, Thomassen M, Caligo MA, Yoon SY, Friedman E, Laitman Y, Borg A, von Wachenfeldt A, Ehrencrona H, Rantala J, Olopade OI, Ganz PA, Nussbaum RL, Gayther SA, Nathanson KL, Domchek SM, Arun BK, Mitchell G, Karlan BY, Lester J, Maskarinec G, Woolcott C, Scott C, Stone J, Apicella C, Tamimi R, Luben R, Khaw KT, Helland A, Haakensen V, Dowsett M, Pharoah PD, Simard J, Hall P, Garcia-Closas M, Vachon C, Chenevix-Trench G, Antoniou AC, Easton DF, Edwards SL. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nature genetics. 2016 Apr;48(4):374-86.   PMCID: 4938803
Zibelman M, Plimack ER. Checkpoint Inhibitors and Urothelial Carcinoma: The Translational Paradigm. Oncology (Williston Park). 2016 Feb;30(2):160-2, 176.
Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML, Nawroth R, Sanchez-Garcia I, Sharma D, Saxena NK, Singh N, Vlachostergios PJ, Guo S, Honoki K, Fujii H, Georgakilas AG, Bilsland A, Amedei A, Niccolai E, Amin A, Ashraf SS, Boosani CS, Guha G, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Keith WN, Nowsheen S. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol. 2015 Dec;35 Suppl:S25-54.   PMCID: PMC4898971
Cancer Genome Atlas Research N. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.   PMCID: 4231481
Lal S, Burkhart RA, Beeharry N, Bhattacharjee V, Londin ER, Cozzitorto JA, Romeo C, Jimbo M, Norris ZA, Yeo CJ, Sawicki JA, Winter JM, Rigoutsos I, Yen TJ, Brody JR. HuR Posttranscriptionally Regulates WEE1: Implications for the DNA Damage Response in Pancreatic Cancer Cells. Cancer Res. 2014 Feb 15;74(4):1128-40.   PMCID: 4353573
Wang K, Sturt-Gillespie B, Hittle JC, Macdonald D, Chan GK, Yen TJ, Liu ST. Thyroid hormone receptor interacting protein 13 (TRIP13) AAA-ATPase is a novel mitotic checkpoint-silencing protein. The Journal of biological chemistry. 2014 Aug 22;289(34):23928-37.   PMCID: Pmc4156041
Guo S, Liu M, Godwin AK. Transcriptional regulation of hTREX84 in human cancer cells. PLoS One. 2012 Jan;7(8):e43610.   PMCID: PMC3428327
Sethi G, Pathak HB, Zhang H, Zhou Y, Einarson MB, Vathipadiekal V, Gunewardena S, Birrer MJ, Godwin AK. An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer. PLoS One. 2012 Oct;7(10):e47086.   PMCID: 3467214
Karbowniczek M, Zitserman D, Khabibullin D, Hartman T, Yu J, Morrison T, Nicolas E, Squillace R, Roegiers F, Henske EP. The evolutionarily conserved TSC/Rheb pathway activates Notch in tuberous sclerosis complex and Drosophila external sensory organ development. J Clin Invest. 2010 Jan;120(1):93-102.   PMCID: PMC2798691
Li C, Andrake M, Dunbrack R, Enders GH. A bifunctional regulatory element in human somatic Wee1 mediates cyclin A/Cdk2 binding and Crm1-dependent nuclear export. Mol Cell Biol. 2010 Jan;30(1):116-30.   PMCID: PMC2798281
Huang H, Yen TJ. BubR1 is an effector of multiple mitotic kinases that specifies kinetochore: microtubule attachments and checkpoint. Cell cycle (Georgetown, Tex). 2009 Apr 15;8(8):1164-7.
Huang H, Hittle J, Zappacosta F, Annan RS, Hershko A, Yen TJ. Phosphorylation sites in BubR1 that regulate kinetochore attachment, tension, and mitotic exit. J Cell Biol. 2008 Nov 17;183(4):667-80.   PMCID: PMC2582891
Adams PD. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene. 2007 Aug;397(1-2):84-93.
Rennefahrt UE, Deacon SW, Parker SA, Devarajan K, Beeser A, Chernoff J, Knapp S, Turk BE, Peterson JR. Specificity profiling of Pak kinases allows identification of novel phosphorylation sites. The Journal of biological chemistry. 2007 May 25;282(21):15667-78.
Zhang R, Chen W, Adams PD. Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol. 2007 Mar;27(6):2343-58.
Noble D, Kenna MA, Dix M, Skibbens RV, Unal E, Guacci V. Intersection between the regulators of sister chromatid cohesion establishment and maintenance in budding yeast indicates a multi-step mechanism. Cell cycle (Georgetown, Tex). 2006 Nov;5(21):2528-36.
Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, Daganzo SM, Erzberger JP, Serebriiskii IG, Canutescu AA, Dunbrack RL, Pehrson JR, Berger JM, Kaufman PD, Adams PD. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Developmental Cell. 2005 Jan;8(1):19-30.
Cvetkovic D, Pisarcik D, Lee C, Hamilton TC, Abdollahi A. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer. Gynecologic Oncology. 2004 Dec;95(3):449-55.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Cell Cycle Proteins

Cell Cycle Proteins genetics metabolism physiology Nuclear Proteins Female pathology Neoplastic Gene Expression Regulation Signal Transduction Cell Line Mutation Phosphorylation RNA Interference drug effects Cell Aging Antineoplastic Agents Amino Acid Sequence Mitosis Carrier Proteins Male Cell Proliferation Cell Cycle Ovarian Neoplasms Protein-Serine-Threonine Kinases chemistry Protein Binding Heterochromatin Transcription Factors Breast Neoplasms Histones Non-Histone Chromosomal Proteins Molecular Sequence Data methods Conserved Sequence pharmacology Neoplastic Cell Transformation Tumor Cell Line Mice Protein-Tyrosine Kinases Cell Nucleus Kinetochores 0 (Transcription Factors) me [Metabolism] Human Chromosomes-Pair 6 therapeutic use Exons Single Nucleotide Polymorphism p53 Genes Neoplastic Stem Cells S Phase 0 (Cell Cycle Proteins) Leukemic Gene Expression Regulation Gene Expression Reverse Transcriptase Polymerase Chain Reaction DNA Sequence Analysis Tertiary Protein Structure Small Interfering RNA Apoptosis Gene Knockdown Techniques Microtubules enzymology Non-US Gov't Research Support Alleles Neoplasm Proteins Amino Acid Motifs Neoplasms Base Sequence ultrastructure Molecular Targeted Therapy Lung Neoplasms Flow Cytometry Mitotic Checkpoint Complex (MCC) PIGN gene expression aberration 129 Strain Mice Cyclin-Dependent Kinase 2 genomic instability 0 (Nuclear Proteins) 0 (Repressor Proteins) Fungal Gene Expression Regulation human) 0 (PLAGL1 protein Western Blotting Gene Expression Profiling Rats Disease Progression E3 Ubiquitin Ligase rho GTP-Binding Proteins Recombinant Fusion Proteins Molecular Models Protein Complex Cell Cycle Checkpoints Cyclin A 0 (macroH2A histone) cdc42 GTP-Binding Protein Anaphase-promoting Complex Carcinoma mortality Cell Nucleus Active Transport Transcriptome embryology protein HP-1) Aging Immunohistochemistry Molecular Typing Site-Directed Mutagenesis Pancreatic Neoplasms deficiency Tuberous Sclerosis Oncogenes Biological Models Phosphotransferases Urothelium G2 Phase ras Proteins therapy Cyclin E Retinoblastoma Genes C) Molecular Chaperones etiology Protein Transport Monomeric GTP-Binding Proteins p31comet Karyopherins Phosphatidylinositol 3-Kinases 0 (Neoplasm Proteins) biosynthesis Treatment Outcome Structure-Activity Relationship Phosphoproteins human) 0 (ASF1A protein Cultured Cells Neuropeptides Myeloid Leukemia-Acute Xenopus 0 (Recombinant Fusion Proteins) Gadd45a Adenocarcinoma ge [Genetics] Bone Marrow Transplantation Evolution Protein Structural Homology ELAV Proteins Diffusion of Innovation Cultured Tumor Cells Therapeutic targets Proteochondroitin Sulfates Spindle Apparatus immunology Knockout Mice human) 143220-95-5 (PML protein
Last updated on Tuesday, June 05, 2018